School of Integrated Health Sciences News
With many degree offerings that are accredited by national organizations, the School of Integrated Health Sciences offers dynamic classroom instruction, laboratory/clinical practice, research, and mentoring. Our students develop skills that help them break into health-related fields and further their graduate or professional studies.
Current Integrated Health Sciences News
Alzheimer’s treatment studies offer hope as UNLV expert predicts new potential drugs, biomarkers will yield critical insight for future development.
Carmen Johnson’s self-determination and empathetic personality has led to an impressive increase in the food pantry's usage.
UNLV Law School has 14 top 100 programs in publication’s 2024 rankings, including No. 2 ranking for legal writing; Physical Therapy cracks top 50.
Professor Chih-Huang "Jeffrey" Yu says the new and unique method can make rehab a more effective experience for patients.
A roundup of the top news stories featuring UNLV students and faculty.
UNLV’s annual crowdfunding drive will raise money on March 21 for scholarships, programs, research, and diverse causes campuswide.
Integrated Health Sciences In The News
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials. And on the heels of newly FDA-approved drugs Aduhelm® (aducanumab) in 2021 and Leqembi® (lecanemab) in 2023, a UNLV researcher says that 2024 is a "learning year" for Alzheimer's drug development.
The world of Alzheimer’s treatments is at an inflection point as more potential drugs make their way out of clinical trials. And on the heels of newly FDA-approved drugs Aduhelm® (aducanumab) in 2021 and Leqembi® (lecanemab) in 2023, a UNLV researcher says that 2024 is a “learning year” for Alzheimer’s drug development.
Considering current developments in Alzheimer’s drugs, a US expert has predicted that the industry should “be prepared for more complex biological therapies that require intravenous infusion and vigilant monitoring for side effects; more like cancer therapies,” according to Dr Jeffrey Cummings, Alzheimer’s clinician-scientist and research professor at the School of Integrated Health Sciences, University of Nevada, Las Vegas.
The world of Alzheimer’s treatments is at an inflection point as more potential drugs make their way out of clinical trials. And on the heels of newly FDA-approved drugs Aduhelm® (aducanumab) in 2021 and Leqembi® (lecanemab) in 2023, a UNLV researcher says that 2024 is a “learning year” for Alzheimer’s drug development.
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials. On the heels of newly FDA-approved drugs Aduhelm (aducanumab) in 2021 and Leqembi (lecanemab) in 2023, a UNLV researcher says that 2024 is a "learning year" for Alzheimer's drug development.
A recent study published in Scientific Reports has found that strength training two to three times per week can be used as an effective treatment for arterial hypertension commonly known as high blood pressure. The researchers from School of Technology and Sciences Sao Paulo State University UNESP in Brazil looked at data from 14 studies featuring 253 participants.